SFD Symposium
The symposium “Antimicrobial therapy: what kind of future awaits” organized by the Serbian Pharmacological Society, is a significant event addressing the evolving landscape of antimicrobial treatments. This gathering brings together leading pharmacologists, microbiologists, and healthcare professionals to discuss the current challenges and future directions in antimicrobial therapy.
Key topics include the rise of antimicrobial resistance, the development of new antibiotics, and alternative therapies. Experts will present the latest research on resistance mechanisms, strategies to combat resistant pathogens, and the importance of antimicrobial stewardship programs. Discussions will also cover the role of vaccines, phage therapy, and the potential of personalized medicine in managing infections.
Through interactive sessions and panel discussions, participants will explore innovative approaches to preserve the efficacy of existing antibiotics and ensure sustainable use of new treatments. This symposium underscores the Serbian Pharmacological Society’s commitment to advancing knowledge and fostering collaboration to address one of the most pressing issues in modern medicine.
Organizing a medical symposium involves meticulous planning and coordination, often requiring the expertise of an event agency. The event agency handles multiple facets of the organization, including venue selection, ensuring it meets the technical and spatial requirements for presentations and workshops. They manage logistics, such as registration processes, accommodation arrangements for speakers and attendees, and transportation. The agency also oversees marketing and promotion, using various channels to attract participants and ensure a successful turnout.
Additionally, the agency coordinates with medical professionals to develop a comprehensive agenda, including keynote speeches, panel discussions, and hands-on sessions. They ensure the availability of necessary equipment, such as audiovisual aids and medical demonstration tools. Attention to detail in catering, adhering to dietary restrictions, and creating a conducive networking environment is also paramount. By handling these aspects, the event agency allows medical experts to focus on content delivery and engagement, ensuring a seamless and impactful symposium.
The Serbian Pharmacological Society is an association of scientific and professional workers dealing with drug-related issues from various perspectives. The initial core of the Society comprised pharmacologists from the Medical, Dental, Veterinary, and Pharmaceutical Faculties, as well as those from the Military Medical Academy.
Today, in addition to basic pharmacologists, the Society’s members include clinical pharmacologists, collaborators from pharmaceutical industries, pharmacists, biologists, chemists, physiologists, pathophysiologists, and others. Within the Society, the Clinical Pharmacology Section operates very successfully, including a number of clinicians engaged in drug testing.
At the beginning, members of the Institute for Clinical Pharmacology, Pharmacology, and Toxicology did not have their own association. From 1951 to 1978, they were members of the Society of Physiologists of Serbia (DFS), as a section of the Union of Physiological Societies of Yugoslavia – SDFJ (formerly the Yugoslav Physiological Association, Yugoslav Society of Physiologists – JDF). From 1978, members of our Institute became part of the Association of Pharmacologists of Serbia, as a section of the Union of Pharmacological Societies of Yugoslavia. At the time of the association’s establishment, the first president was Prof. Varagić, followed by Prof. Bogdan Bošković (VMA) and Prof. Milovan Krstić. Under the leadership of Prof. Krstić, a very successful researcher, the Society remained active through the 1990s, continuing fruitful scientific activity, international cooperation, and reorganization (establishing the Clinical Pharmacology Section). Later, Prof. Ranka Samardžić became the president of the Society from 1998 to 2002. From 2002 to 2005, the president was Prof. Kornelija Švajcer-Đaković, and from 2005 to 2008, it was Prof. Dubravko Bokonjić. The current president is Prof. Ljiljana Gojković-Bukarica, and the Society is still headquartered in Belgrade, at our institute’s premises. The Society has over 100 members.
In 1994, the Clinical Pharmacology Section of the Society was established. The founder and first president was Prof. Tomislav Kažić. Subsequent presidents were Prof. Milan Stanulović, Prof. Miloš Stojiljković, and the current president of the section is Prof. Ana Sabo. The Section is a member of the European Association for Clinical Pharmacology and Therapeutics (EACPT). The Section has over 100 members.
